Kamada Ltd. (KMDA)
8.08
+0.30
(+3.92%)
USD |
NASDAQ |
Oct 09, 16:00
8.07
-0.01
(-0.12%)
Pre-Market: 20:00
Kamada Price to Book Value : 1.729 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.729 |
| October 08, 2026 | 1.664 |
| October 07, 2026 | 1.689 |
| October 06, 2026 | 1.736 |
| October 05, 2026 | 1.712 |
| October 02, 2026 | 1.779 |
| October 01, 2026 | 1.755 |
| September 30, 2026 | 1.811 |
| September 29, 2026 | 1.861 |
| September 28, 2026 | 1.845 |
| September 25, 2026 | 1.866 |
| September 24, 2026 | 1.890 |
| September 23, 2026 | 1.877 |
| September 22, 2026 | 1.898 |
| September 21, 2026 | 1.871 |
| September 18, 2026 | 1.894 |
| September 17, 2026 | 1.856 |
| September 16, 2026 | 1.753 |
| September 15, 2026 | 1.732 |
| September 14, 2026 | 1.779 |
| September 11, 2026 | 1.695 |
| September 10, 2026 | 1.710 |
| September 09, 2026 | 1.757 |
| September 08, 2026 | 1.774 |
| September 04, 2026 | 1.828 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.770 |
| September 02, 2026 | 1.798 |
| September 01, 2026 | 1.794 |
| August 31, 2026 | 1.762 |
| August 28, 2026 | 1.774 |
| August 27, 2026 | 1.768 |
| August 26, 2026 | 1.794 |
| August 25, 2026 | 1.847 |
| August 24, 2026 | 1.804 |
| August 21, 2026 | 1.764 |
| August 20, 2026 | 1.716 |
| August 19, 2026 | 1.689 |
| August 18, 2026 | 1.689 |
| August 17, 2026 | 1.661 |
| August 14, 2026 | 1.622 |
| August 13, 2026 | 1.554 |
| August 12, 2026 | 1.472 |
| August 11, 2026 | 1.518 |
| August 10, 2026 | 1.528 |
| August 07, 2026 | 1.556 |
| August 06, 2026 | 1.528 |
| August 05, 2026 | 1.537 |
| August 04, 2026 | 1.571 |
| August 03, 2026 | 1.548 |
| July 31, 2026 | 1.528 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.703 |
| XTL Biopharmaceuticals Ltd. | -- |
| Can-Fite BioPharma Ltd. | 1.380 |
| Eocene Ltd. | 0.2783 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 21.17 |
| PS Ratio | 2.474 |
| PEG Ratio | 1.370 |
| Price to Free Cash Flow | 17.18 |
| Price | 8.08 |
| Earnings Yield | 4.72% |
| Market Cap | 466.17M |
| PEGY Ratio | 1.025 |
| Operating PE Ratio | 17.06 |
| Normalized PE Ratio | 20.63 |